iPS-ML/IFN-β and iPS -ML/anti-HER2/IFN-β were equivalently effective, indicating that expression of anti-HER2 is dispensable for anti-cancer effect of iPS-ML producing IFN-β. Here, ERBB2 is linked to cancer.